phenylalanine has been researched along with rifamycins in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, WL; Jiao, RS; Xia, TH | 1 |
| Busiello, E; Di Girolamo, A; Di Girolamo, M; Fischer-Fantuzzi, L; Vesco, C | 1 |
| Allocati, N; Casalone, E; Di Ilio, C; Masulli, M; Parker, MW; Polekhina, G; Rossjohn, J | 1 |
| Ervin, CM; Mangel, AW | 1 |
| Lembo, AJ; Nee, J; Zakari, M | 1 |
| Cash, BD; Earnest, DL; Lacy, BE; Rao, T | 1 |
| Rivkin, A; Rybalov, S | 1 |
| Morgan, B | 1 |
| Lacy, BE; Moreau, JC | 1 |
| Talley, NJ | 1 |
| Weber, HC | 1 |
| Boeckxstaens, G; Camilleri, M | 1 |
7 review(s) available for phenylalanine and rifamycins
| Article | Year |
|---|---|
Clinical trials in irritable bowel syndrome: a review.
Topics: Alprostadil; Benzamides; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbolines; Dose-Response Relationship, Drug; Gastrointestinal Agents; Humans; Indoles; Irritable Bowel Syndrome; Lubiprostone; Peptides; Phenylalanine; Phloroglucinol; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2013 |
Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome.
Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin | 2015 |
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
Topics: Abdominal Pain; Anti-Bacterial Agents; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Narcotic Antagonists; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists | 2016 |
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
Topics: Administration, Oral; Diarrhea; Disease Management; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin | 2016 |
Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations.
Topics: Carbolines; Diarrhea; Disease Management; Humans; Imidazoles; Irritable Bowel Syndrome; Parasympatholytics; Phenylalanine; Rifamycins; Rifaximin; United States | 2016 |
New treatment options for irritable bowel syndrome with predominant diarrhea.
Topics: Anti-Bacterial Agents; Constipation; Diarrhea; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Narcotic Antagonists; Phenylalanine; Quality of Life; Receptors, Opioid; Rifamycins; Rifaximin | 2017 |
Dietary and pharmacological treatment of abdominal pain in IBS.
Topics: Abdominal Pain; Anti-Infective Agents; Antidepressive Agents; Butyrophenones; Dipeptides; GABA Agents; Gastrointestinal Agents; Histamine H1 Antagonists; Humans; Imidazoles; Irritable Bowel Syndrome; Mentha piperita; Parasympatholytics; Phenylalanine; Piperidines; Plant Oils; Probiotics; Quaternary Ammonium Compounds; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists; Thiophenes; Visceral Pain | 2017 |
6 other study(ies) available for phenylalanine and rifamycins
| Article | Year |
|---|---|
[Regulatory effects of terminal products and intermediates of aromatic pathways on rifamycin biosynthesis in Nocardia mediterranei].
Topics: 3-Deoxy-7-Phosphoheptulonate Synthase; 4-Aminobenzoic Acid; Aldehyde-Lyases; Nocardia; Parabens; Phenylalanine; Rifamycins; Tryptophan; Tyrosine | 1988 |
Multiple effects of rifamycin derivatives on animal-cell metabolism of macromolecules.
Topics: Animals; Cell Nucleolus; Cell Nucleus; Cell-Free System; Chromatography, DEAE-Cellulose; DNA; DNA-Directed RNA Polymerases; HeLa Cells; In Vitro Techniques; Liver; Mice; Oligopeptides; Phenylalanine; Protein Biosynthesis; Rats; Reticulocytes; Rifamycins; RNA, Ribosomal; Structure-Activity Relationship | 1973 |
Evaluation of the role of two conserved active-site residues in beta class glutathione S-transferases.
Topics: Alanine; Amino Acid Sequence; Anti-Bacterial Agents; Arginine; Asparagine; Binding Sites; Catalysis; Conserved Sequence; Dose-Response Relationship, Drug; Escherichia coli; Glutathione Transferase; Guanidine; Histidine; Lysine; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Protein Binding; Protein Conformation; Protein Folding; Protein Structure, Secondary; Proteus mirabilis; Rifamycins; Spectrometry, Fluorescence; Temperature; Time Factors | 2000 |
The latest drug therapies for treating IBS. Longtime sufferers of irritable bowel syndrome have new options for relief.
Topics: Chronic Disease; Drug Approval; Gastrointestinal Agents; Humans; Imidazoles; Peptides; Phenylalanine; Rifamycins; Rifaximin; United States; United States Food and Drug Administration | 2015 |
Drug development: A healthy pipeline.
Topics: Animals; Benzimidazoles; Benzofurans; Bile Acids and Salts; Carbolines; Colesevelam Hydrochloride; Colestipol; Disease Models, Animal; Enteric Nervous System; Female; Humans; Imidazoles; Indoles; Irritable Bowel Syndrome; Loperamide; Lubiprostone; Male; Mice; Natriuretic Peptides; Peptides; Phenylalanine; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Rifamycins; Rifaximin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Visceral Pain | 2016 |
Board Review Vignette: Irritable Bowel Syndrome.
Topics: Abdominal Pain; Adult; Anion Exchange Resins; Antidiarrheals; Carbolines; Cholestyramine Resin; Constipation; Diarrhea; Disease Management; Female; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Imidazoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Peptides; Phenylalanine; Probiotics; Rifamycins; Rifaximin; Selective Serotonin Reuptake Inhibitors | 2016 |